Header a MOSA O2

Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias

HOME

Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias

Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias
Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias
Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias
Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias

CONTACT

Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias

3D Map of the Americas - MOSA - Medical Oxygen Society of the Americas

Header Logo - MOSA - Medical Oxygen Society of the Americas
Google Language Translator - MOSA - Medical Oxygen Society of the Americas - www.mosao2.org
   
   
HOME PAGE menu white arrow - MOSA - www.mosao2.org - Medical Oxygen Society of the Americas
NEWS / RESEARCH menu white arrow - MOSA - www.mosao2.org - Medical Oxygen Society of the Americas
   

bg grey mosao2

MOSA Membership - Click Here to Enroll - www.mosao2.org - Medical Oxygen Society of the Americas
bg grey mosao2

MOSA Newsletter - Sign Up Here - www.mosao2.org - Medical Oxygen Society of the Americas

bg grey mosao2
MOSA Study Groups - Sign Up Here - www.mosao2.org - Medical Oxygen Society of the Americas
bg grey mosao2
 
Spacer - MOSA - Medical Oxygen Society of the Americas - www.mosao2.org


MOSA - Article

Spacer - MOSA - Medical Oxygen Society of the Americas - www.mosao2.org


Oxygen Medicine Nutrition - Tea:

Tea Antioxidants in Cancer Chemo Prevention

Logo - MOSA - Medical Oxygen Society of the Americas
Spacer - MOSA - Medical Oxygen Society of the Americas - www.mosao2.org

 

http://www.ncbi.nlm.nih.gov/pubmed/9591194

 

J Cell Biochem Suppl. 1997;27:59-67.

Katiyar SK, Mukhtar H.

Source

Department of Dermatology, University Hospitals of Cleveland, Ohio 44106-5028, USA.

 

 

Tea Antioxidants in Cancer Chemo Prevention

 

Abstract

In recent years, the concept of cancer chemoprevention has matured greatly. Significant reversal or suppression of premalignancy in several sites by chemopreventive agents appears achievable.

 

This article summarizes experimental data on chemopreventive effects of tea polyphenols in different tumor bioassay systems. Tea (Camellia sinensis) is cultivated in about 30 countries, and is the most widely consumed beverage in the world.

 

Three main commercial tea varieties--green, black, and oolong--are usually consumed, but most experimental studies demonstrating the antimutagenic and anticarcinogenic effects of tea have been conducted with water extract of green tea, or a polyphenolic fraction isolated from green tea (GTP).

 

The majority of these studies have been conducted in a mouse skin tumor model system where tea is fed either as water extract through drinking water, or as purified GTP. GTP has been shown to exhibit antimutagenic activity in vitro, and inhibit carcinogen- as well as UV-induced skin carcinogenesis in vivo. 

 

Tea consumption has also been shown to afford protection against chemical carcinogen-induced stomach, lung, esophagus, duodenum, pancreas, liver, breast, and colon carcinogenesis in specific bioassay models.

 

Several epicatechin derivatives (polyphenols) present in green tea have been shown to possess anticarcinogenic activity; the most active is (-)-epigallocatechin-3-gallate, which is also the major constituent of GTP.

 

The mechanisms of tea's broad cancer chemopreventive effects are not completely understood. Several theories have been put forward, including inhibition of UV- and tumor promoter-induced ornithine decarboxylase, cyclo-oxygenase, and lipoxygenase activities, antioxidant and free radical scavenging activity; enhancement of antioxidant (glutathione peroxidase, catalase, and quinone reductase) and phase II (glutathione-S-transferase) enzyme activities; inhibition of lipid peroxidation, and anti-inflammatory activity.

 

These properties of tea polyphenols make them effective chemopreventive agents against the initiation, promotion, and progression stages of multistage carcinogenesis.

PMID: 9591194 [PubMed - indexed for MEDLINE]

 

________________________________________

 

 

http://www.ncbi.nlm.nih.gov/pubmed/9591194

 

   

 

 

Copyright @ 2011 www.mosa02.com. All Rights Reserved.


Disclaimer:

While every effort has been made to ensure that the information and data provided on this website are correct, no guarantee can be provided that
the information it contains is completely error-free. MOSA shall not be held liable for information and data that is not up-to-date, correct or complete.

MOSA reserves the right to edit, change or add to the information and data provided without prior notice. This website is produced and published
so that you can broaden your health education and options. Please consult your physician before considering any therapy.